Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Assay and Drug Development Technologies
|
January 4, 2007
Automated Tecan programming for bioanalytical sample preparation with EZTecan
Huidong Gu, Steve Unger, Yuzhong Deng
Nephrology (Carlton, Vic.)
|
March 16, 2013
Value of myocardial perfusion imaging in renal transplant evaluation
Chong Ghee Chew, Steve Unger, Sepehr Shakib
Journal of Pharmaceutical and Biomedical Analysis
|
March 15, 2006
A 96-well single-pot liquid-liquid extraction, hydrophilic interaction liquid chromatography-mass spectrometry method for the determination of muraglitazar in human plasma
Y-J Xue, Jane Liu, Steve Unger
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 27, 2002
Development and validation of a liquid chromatography-mass spectrometric method for the determination of DPC 423, an antithrombotic agent, in rat and dog plasma
Cecilia Chi, Li Liang, Patty Padovani, et al.
Bioanalysis
|
November 16, 2019
The impact of hemolysis on stability of <i>N</i>-desethyloxybutynin in human plasma
Zhixin Miao, Melvin Tan, Edward Wells, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
January 4, 2006
A 96-well single-pot protein precipitation, liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of muraglitazar, a novel diabetes drug, in human plasma
Y-J Xue, Jane Liu, Janice Pursley, et al.
Bioanalysis
|
June 25, 2014
The science of laboratory and project management in regulated bioanalysis
Steve Unger, Thomas Lloyd, Melvin Tan, et al.
Journal of Separation Science
|
July 12, 2007
Quantitative determination of BMS-378806 in human plasma and urine by high-performance liquid chromatography/tandem mass spectrometry
Y J Xue, Jing-He Yan, Mark Arnold, et al.
Bioanalysis
|
March 11, 2011
Unique challenges of providing bioanalytical support for biological therapeutic pharmacokinetic programs
William L Nowatzke, Kathryn Rogers, Edward Wells, et al.
Journal of Pharmaceutical Sciences
|
July 23, 2011
The impact of decreased bead count to determine concentrations of amyloid beta1-42, total-tau, and phosphorylated-tau181 in human cerebrospinal fluid using xMAP technology
Olaf Bjornstal, Kathryn Rogers, Wei Zhang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Assay and Drug Development Technologies
|
January 4, 2007
Automated Tecan programming for bioanalytical sample preparation with EZTecan
Huidong Gu, Steve Unger, Yuzhong Deng
Nephrology (Carlton, Vic.)
|
March 16, 2013
Value of myocardial perfusion imaging in renal transplant evaluation
Chong Ghee Chew, Steve Unger, Sepehr Shakib
Journal of Pharmaceutical and Biomedical Analysis
|
March 15, 2006
A 96-well single-pot liquid-liquid extraction, hydrophilic interaction liquid chromatography-mass spectrometry method for the determination of muraglitazar in human plasma
Y-J Xue, Jane Liu, Steve Unger
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 27, 2002
Development and validation of a liquid chromatography-mass spectrometric method for the determination of DPC 423, an antithrombotic agent, in rat and dog plasma
Cecilia Chi, Li Liang, Patty Padovani, et al.
Bioanalysis
|
November 16, 2019
The impact of hemolysis on stability of <i>N</i>-desethyloxybutynin in human plasma
Zhixin Miao, Melvin Tan, Edward Wells, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
January 4, 2006
A 96-well single-pot protein precipitation, liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of muraglitazar, a novel diabetes drug, in human plasma
Y-J Xue, Jane Liu, Janice Pursley, et al.
Bioanalysis
|
June 25, 2014
The science of laboratory and project management in regulated bioanalysis
Steve Unger, Thomas Lloyd, Melvin Tan, et al.
Journal of Separation Science
|
July 12, 2007
Quantitative determination of BMS-378806 in human plasma and urine by high-performance liquid chromatography/tandem mass spectrometry
Y J Xue, Jing-He Yan, Mark Arnold, et al.
Bioanalysis
|
March 11, 2011
Unique challenges of providing bioanalytical support for biological therapeutic pharmacokinetic programs
William L Nowatzke, Kathryn Rogers, Edward Wells, et al.
Journal of Pharmaceutical Sciences
|
July 23, 2011
The impact of decreased bead count to determine concentrations of amyloid beta1-42, total-tau, and phosphorylated-tau181 in human cerebrospinal fluid using xMAP technology
Olaf Bjornstal, Kathryn Rogers, Wei Zhang, et al.
Page
of 2